State-by-State Cannabis Report

U.S. health officials have recommended a loosening of restrictions on marijuana, potentially paving the way for an expansion of the national cannabis market. A high-ranking Department of Health and Human Services official penned a letter urging the Drug Enforcement Agency to reclassify marijuana as a Schedule III drug under the Controlled Substances Act, a move that would signify a significant departure from its current Schedule I status associated with high abuse risk. While not full legalization, this change could be instrumental in reducing taxes on cannabis businesses and encouraging banks and financial institutions to offer traditional banking services to cannabis companies. The announcement led to a surge in marijuana stocks, with the MJ PurePlay 100 Index climbing 13%, showcasing the potential economic impact of such a regulatory shift. (Source: Bloomberg)